| pubmed-article:7589165 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C0025255 | lld:lifeskim |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C0205145 | lld:lifeskim |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C0109817 | lld:lifeskim |
| pubmed-article:7589165 | lifeskim:mentions | umls-concept:C0259952 | lld:lifeskim |
| pubmed-article:7589165 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7589165 | pubmed:dateCreated | 1995-12-12 | lld:pubmed |
| pubmed-article:7589165 | pubmed:abstractText | Two classes of high-affinity sites for [3H]cirazoline were characterized in rat brain and kidney membranes. In both tissues, the binding parameters for the high- and low-affinity sites are similar with Bmax values of approximately 50 fmol/mg protein, Kd approximately 0.6 nM and Bmax approximately 470 fmol/mg protein, Kd approximately 11 nM respectively. Inhibition studies of [3H]cirazoline binding to the lower affinity site revealed that only guanidinium or imidazoline derivatives compete with the specific binding of this radioligand. Our results suggest that [3H]cirazoline could be used as a novel ligand to label the non-adrenergic imidazoline-preferring sites. | lld:pubmed |
| pubmed-article:7589165 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7589165 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7589165 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7589165 | pubmed:month | May | lld:pubmed |
| pubmed-article:7589165 | pubmed:issn | 0014-2999 | lld:pubmed |
| pubmed-article:7589165 | pubmed:author | pubmed-author:LangerS ZSZ | lld:pubmed |
| pubmed-article:7589165 | pubmed:author | pubmed-author:AllenJJ | lld:pubmed |
| pubmed-article:7589165 | pubmed:author | pubmed-author:ArbillaSS | lld:pubmed |
| pubmed-article:7589165 | pubmed:author | pubmed-author:AngelII | lld:pubmed |
| pubmed-article:7589165 | pubmed:author | pubmed-author:SchoemakerHH | lld:pubmed |
| pubmed-article:7589165 | pubmed:author | pubmed-author:Le RouzicMM | lld:pubmed |
| pubmed-article:7589165 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7589165 | pubmed:day | 24 | lld:pubmed |
| pubmed-article:7589165 | pubmed:volume | 278 | lld:pubmed |
| pubmed-article:7589165 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7589165 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7589165 | pubmed:pagination | 261-4 | lld:pubmed |
| pubmed-article:7589165 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:meshHeading | pubmed-meshheading:7589165-... | lld:pubmed |
| pubmed-article:7589165 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7589165 | pubmed:articleTitle | Binding of [3H]cirazoline to an imidazoline site in rat brain and kidney membranes. | lld:pubmed |
| pubmed-article:7589165 | pubmed:affiliation | Synthelabo Research, Department of Preclinical Research, Bagneux, France. | lld:pubmed |
| pubmed-article:7589165 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7589165 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7589165 | lld:pubmed |
